MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basu, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basu, A.

Vol. 53, Issue 1, 105-111, January 1998

The Involvement of Novel Protein Kinase C Isozymes in Influencing Sensitivity of Breast Cancer MCF-7 Cells to Tumor Necrosis Factor-alpha

Alakananda Basu

Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261

Protein kinase C (PKC) has been implicated in tumor necrosis factor-alpha (TNF) signaling. Structurally and functionally distinct PKC activators and selective inhibitors of PKC were used to investigate the involvement of PKC isozymes in influencing TNF sensitivity in MCF-7 cells. Activators of PKC, such as phorbol-12,13-dibutyrate (PDBu) (1.0 µM), indolactam V (10 µM), and bryostatin 1 (1.0 µM) decreased the sensitivity of MCF-7 cells to TNF by 5-, 10-, and 1.7-fold, respectively. The PKC-specific inhibitor bisindolylmaleimide II (BIM) (>= 1 µM) antagonized the effect of PDBu in protecting MCF-7 cells against TNF cytotoxicity. High concentrations of BIM (>= 10 µM) also significantly enhanced the sensitivity of MCF-7 cells to TNF. In contrast, Gö 6976, a specific inhibitor of cPKCs, did not potentiate TNF sensitivity and failed to reverse the effect of PDBu. In addition, BIM but not Gö 6976 blocked PDBu-mediated down-regulation of TNF receptors. There was no correlation between down-regulation of PKCalpha , -delta , and -epsilon , and protection against TNF cytotoxicity by PKC activators. A 6-hr exposure to 1.0 µM PDBu, 10 µM indolactam V, and 1.0 µM bryostatin 1 caused a 1.8-, 3.5- and 1.2-fold induction, respectively, of nPKCeta in MCF-7 cells. Similar exposure to BIM but not Gö 6976 led to a significant down-regulation of nPKCeta . This novel regulation of PKCeta implicates this isozyme in PDBu-mediated protection of MCF-7 cells against TNF cytotoxicity.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
N. Kucic, H. Mahmutefendic, and P. Lucin
Inhibition of protein kinases C prevents murine cytomegalovirus replication
J. Gen. Virol., August 1, 2005; 86(8): 2153 - 2161.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Sonnemann, V. Gekeler, A. Sagrauske, C. Muller, H.-P. Hofmann, and J. F. Beck
Down-regulation of protein kinase C{eta} potentiates the cytotoxic effects of exogenous tumor necrosis factor-related apoptosis-inducing ligand in PC-3 prostate cancer cells
Mol. Cancer Ther., July 1, 2004; 3(7): 773 - 781.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. D. Boyan, V. L. Sylvia, T. Frambach, C. H. Lohmann, J. Dietl, D. D. Dean, and Z. Schwartz
Estrogen-Dependent Rapid Activation of Protein Kinase C in Estrogen Receptor-Positive MCF-7 Breast Cancer Cells and Estrogen Receptor-Negative HCC38 Cells Is Membrane-Mediated and Inhibited by Tamoxifen
Endocrinology, May 1, 2003; 144(5): 1812 - 1824.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Basu, D. Lu, B. Sun, A. N. Moor, G. R. Akkaraju, and J. Huang
Proteolytic Activation of Protein Kinase C-epsilon by Caspase-mediated Processing and Transduction of Antiapoptotic Signals
J. Biol. Chem., October 25, 2002; 277(44): 41850 - 41856.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
S. K. Davidson, S. W. Allen, G. E. Lim, C. M. Anderson, and M. G. Haygood
Evidence for the Biosynthesis of Bryostatins by the Bacterial Symbiont ""Candidatus Endobugula sertula"" of the Bryozoan Bugula neritina
Appl. Envir. Microbiol., October 1, 2001; 67(10): 4531 - 4537.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Laouar, D. Glesne, and E. Huberman
Involvement of Protein Kinase C-beta and Ceramide in Tumor Necrosis Factor-alpha -induced but Not Fas-induced Apoptosis of Human Myeloid Leukemia Cells
J. Biol. Chem., August 13, 1999; 274(33): 23526 - 23534.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. E. Remmers, M. J. Clark, X. Y. Liu, and F. Medzihradsky
Delta Opioid Receptor Down-Regulation Is Independent of Functional G Protein yet Is Dependent on Agonist Efficacy
J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 625 - 632.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. S. Resnick, B.-S. Kang, D. Luu, J. T. Wickham, J. J. Sando, and C. S. Hahn
Differential Downstream Functions of Protein Kinase Ceta and -theta in EL4 Mouse Thymoma Cells
J. Biol. Chem., October 16, 1998; 273(42): 27654 - 27661.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. M. Hussaini, L. R. Karns, G. Vinton, J. E. Carpenter, G. T. Redpath, J. J. Sando, and S. R. VandenBerg
Phorbol 12-Myristate 13-Acetate Induces Protein Kinase Ceta -specific Proliferative Response in Astrocytic Tumor Cells
J. Biol. Chem., July 14, 2000; 275(29): 22348 - 22354.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics